Drug resistance and the microenvironment: nature and nurture.
about
Molecular mechanisms of chemoresistance in gastric cancerAn integrated computational/experimental model of lymphoma growthDesigning a broad-spectrum integrative approach for cancer prevention and treatment.Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment.Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast.Hypoxia-inducible factor 1alpha determines gastric cancer chemosensitivity via modulation of p53 and NF-kappaBHIF-1α inhibition reverses multidrug resistance in colon cancer cells via downregulation of MDR1/P-glycoprotein.Cancer and the tumor microenvironment: a review of an essential relationship.Carcinoma matrix controls resistance to cisplatin through talin regulation of NF-kB3D collagen type I matrix inhibits the antimigratory effect of doxorubicin.Integrin αβ1, αvβ, α6β effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance.Deciphering cellular states of innate tumor drug responses.Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype.Design of a doxorubicin-peptidomimetic conjugate that targets HER2-positive cancer cells.An increase in glucosylceramide synthase induces Bcl-xL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells.An integrative model for recurrence in ovarian cancer.Broad targeting of resistance to apoptosis in cancer.Fibroblast-derived 3D matrix differentially regulates the growth and drug-responsiveness of human cancer cellsIncreased Expression of Several Collagen Genes is Associated with Drug Resistance in Ovarian Cancer Cell LinesDeregulation of let-7e in epithelial ovarian cancer promotes the development of resistance to cisplatin.Prediction of drug response in breast cancer using integrative experimental/computational modeling.Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agentsNovel strategies for reversing platinum resistance.The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer.Hepatic carcinoma-associated fibroblasts promote an adaptative response in colorectal cancer cells that inhibit proliferation and apoptosis: nonresistant cells die by nonapoptotic cell death.MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells.WWOX modulates the gene expression profile in the T98G glioblastoma cell line rendering its phenotype less malignantEmerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms.Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress.Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.Extracellular matrix proteins modulate antimigratory and apoptotic effects of Doxorubicin.Regulatory role of CCN3 in melanoma cell interaction with the extracellular matrix.Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma.Organotypic culture of breast tumor explants as a multicellular system for the screening of natural compounds with antineoplastic potential.Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis.The significance of lumican expression in ovarian cancer drug-resistant cell lines.Microfluidics Enabled Bottom-Up Engineering of 3D Vascularized Tumor for Drug Discovery.miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy.IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.Effects of proton pump inhibitors on reversing multidrug resistance via downregulating V-ATPases/PI3K/Akt/mTOR/HIF-1α signaling pathway through TSC1/2 complex and Rheb in human gastric adenocarcinoma cells in vitro and in vivo
P2860
Q28069259-6AC086B7-6D2D-4332-B606-0D38B83B0684Q28489081-016A12AF-76CC-4474-98E0-75CBAD3905DEQ30736359-65ED44A7-4827-4937-8E67-9F4053E0986BQ33239295-20F814C8-0029-4B45-90DB-73DE972A48EDQ33392443-6025E51E-E56D-475B-A760-B57C5466CC0BQ33656653-692DB05F-3868-4633-B903-E819390EB42BQ33717131-4D26CE10-2AB3-4823-8E10-A80D9C8A0DBBQ33806357-2225A78B-5C98-4C58-A9D9-7F50601BA03CQ33947972-046EB7E4-1661-4E94-96B0-AB79DA6CC7DEQ34084025-783C8415-F6AB-49D5-BBA7-5048DA730A30Q35008834-EB81D108-95FC-45CF-9CF0-5DB9973CA175Q35012940-572B79D8-6E89-45B3-872E-692ED8262BC8Q35612803-3FDC385D-A8C4-419A-8333-63C94BED20E9Q36171074-041EE5A1-57E3-426B-B25B-3504B8D827E4Q36299738-D711A38E-9DEB-4DBC-BE6B-1B6B67C4BA41Q36470173-0BD587A6-C203-4D13-BBDB-261FD81AFC5CQ36483749-5BA2BB97-3509-436D-B99D-624D611A28E3Q37016649-28DA710A-2944-4A9E-8A56-9FA3E0D8D95DQ37068010-6A793DFF-0044-42E5-AB5C-DF50A243EB36Q37275739-0545310E-2844-4D4E-AFF8-1EC6B267B0E9Q37288570-EBD0FACA-FD9F-4225-B384-96E7CE28444AQ37330876-6D51751F-9BA2-40F7-ACD1-8A1A2BE00A60Q37461061-C5912426-6F07-40CD-B16F-F2503CC9B8F2Q38654867-A201A5A5-7D4F-4B03-A6F0-15CC515F78D9Q38826311-A6DA19EA-9119-4AC3-81FC-647ECC4F11AFQ38960629-5282BEDF-52E5-4F90-86E6-742DB022E82DQ38972730-077C65BB-F191-4DCB-AE7A-FDC5878B6315Q39139241-102028E7-9313-4CBC-A1DF-F839026551D1Q39346123-D4C71B43-0FC0-4B04-8861-7AD5ACA0E5A4Q40214416-800DDC03-183D-4CA8-A343-22D7C827B3DAQ41967456-4CFADB74-8E0B-42E3-A78D-BCFC4E7ED956Q42062594-95B08176-1549-495E-B9EA-E58C453F5B23Q42468364-05E0CD49-1905-4729-B11E-26409FD84579Q43249219-6D21F425-4959-4AEB-9A12-E36DDA7C40DAQ44092872-B1F87F7E-BC5B-43B6-BA5E-BCA50AD34319Q47132524-465AD135-808D-4A4D-A344-C7F8A1086F16Q48018893-407546C2-925F-4D33-B5C3-FEB214FA1C29Q49515320-52B48C40-EABF-427B-8ED2-018BE8A77765Q50068814-3E11A2D1-FF9F-4C3F-BD8E-C0B76D9EFD24Q57816333-6863B35B-82D3-465B-A939-66AED8E6767F
P2860
Drug resistance and the microenvironment: nature and nurture.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Drug resistance and the microenvironment: nature and nurture.
@ast
Drug resistance and the microenvironment: nature and nurture.
@en
type
label
Drug resistance and the microenvironment: nature and nurture.
@ast
Drug resistance and the microenvironment: nature and nurture.
@en
prefLabel
Drug resistance and the microenvironment: nature and nurture.
@ast
Drug resistance and the microenvironment: nature and nurture.
@en
P1476
Drug resistance and the microenvironment: nature and nurture.
@en
P2093
Patrice J Morin
P304
P356
10.1016/S1368-7646(03)00059-1
P577
2003-08-01T00:00:00Z